Literature DB >> 6089105

Trans activation of plasmid-borne promoters by adenovirus and several herpes group viruses.

R D Everett, M Dunlop.   

Abstract

This paper describes experiments to test the ability of a number of viruses of the Herpes group, and also Adenovirus-2 and SV40, to activate transcription from the Herpes simplex virus-1 glycoprotein D and the rabbit beta-globin promoters. Plasmids containing these genes were transfected into HeLa cells which were then infected with various viruses. Transcriptional activation in trans of the plasmid-borne promoters was monitored by quantitative S1 nuclease analysis of total cytoplasmic RNA isolated after infection. The results showed that Herpes simplex viruses 1 and 2, Pseudorabies virus, Variella Zoster virus, Human Cytomegalovirus, Equine herpes virus-1 and Adenovirus-2 activate transcription from both promoters tested. In contrast, SV40 did not activate transcription in trans in this assay. The possible mechanisms of this activation are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089105      PMCID: PMC320050          DOI: 10.1093/nar/12.15.5969

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Regulation of herpesvirus macromolecular synthesis. VIII. The transcription program consists of three phases during which both extent of transcription and accumulation of RNA in the cytoplasm are regulated.

Authors:  P C Jones; B Roizman
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

2.  Temporal regulation of herpes simplex virus type 1 transcription: location of transcripts on the viral genome.

Authors:  J B Clements; R J Watson; N M Wilkie
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

3.  Anatomy of herpes simplex virus DNA VII. alpha-RNA is homologous to noncontiguous sites in both the L and S components of viral DNA.

Authors:  P C Jones; G S Hayward; B Roizman
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

4.  An adenovirus type 5 early gene function regulates expression of other early viral genes.

Authors:  N Jones; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

5.  Regulation of synthesis of herpes simplex type 1 virus mRNA during productive infection.

Authors:  R I Swanstrom; E K Wagner
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

6.  The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants.

Authors:  P Moreau; R Hen; B Wasylyk; R Everett; M P Gaub; P Chambon
Journal:  Nucleic Acids Res       Date:  1981-11-25       Impact factor: 16.971

7.  A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis.

Authors:  R J Watson; J B Clements
Journal:  Nature       Date:  1980-05-29       Impact factor: 49.962

8.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

Authors:  A J Berk; F Lee; T Harrison; J Williams; P A Sharp
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

9.  Herpes simplex virus gene expression in transformed cells. I. Regulation of the viral thymidine kinase gene in transformed L cells by products of superinfecting virus.

Authors:  J M Leiden; R Buttyan; P G Spear
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

10.  Active viral genes in transformed cells lie close to the nuclear cage.

Authors:  P R Cook; J Lang; A Hayday; L Lania; M Fried; D J Chiswell; J A Wyke
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  40 in total

Review 1.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

2.  Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression.

Authors:  F S Leach; E S Mocarski
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  Both the rightward and the leftward open reading frames within the BamHI M DNA fragment of Epstein-Barr virus act as trans-activators of gene expression.

Authors:  M O Oguro; N Shimizu; Y Ono; K Takada
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Direct correlation between a negative autoregulatory response element at the cap site of the herpes simplex virus type 1 IE175 (alpha 4) promoter and a specific binding site for the IE175 (ICP4) protein.

Authors:  M S Roberts; A Boundy; P O'Hare; M C Pizzorno; D M Ciufo; G S Hayward
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

5.  Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts.

Authors:  R R Spaete; E S Mocarski
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

6.  Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; A Dolan; S Donald; D H Brauer
Journal:  Nucleic Acids Res       Date:  1986-02-25       Impact factor: 16.971

7.  Isolation of cDNA clones derived from a cellular gene transcriptionally induced by herpes simplex virus.

Authors:  R Patel; W L Chan; L M Kemp; N B La Thangue; D S Latchman
Journal:  Nucleic Acids Res       Date:  1986-07-25       Impact factor: 16.971

8.  Regulation of transcription in vitro from herpes simplex virus genes.

Authors:  L I Pizer; D G Tedder; J L Betz; K W Wilcox; P Beard
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

9.  Molecular cloning of DNA sequences from cervical intraepithelial neoplasia that hybridize to human cytomegalovirus DNA.

Authors:  K Fletcher; J C Macnab
Journal:  Virus Genes       Date:  1989-08       Impact factor: 2.332

10.  Induction of interleukin-8 gene expression is associated with herpes simplex virus infection of human corneal keratocytes but not human corneal epithelial cells.

Authors:  J E Oakes; C A Monteiro; C L Cubitt; R N Lausch
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.